0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Insulin Like Growth Factor II Market Insights, Forecast to 2028
Published Date: April 2022
|
Report Code: QYRE-Auto-23R334
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Insulin Like Growth Factor II Market Insights Forecast to 2028

Global Insulin Like Growth Factor II Market Insights, Forecast to 2028

Code: QYRE-Auto-23R334
Report
April 2022
73 Pages
QYResearch
Region: Global, Europe, North America, India, Japan, Southeast Asia,
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Insulin Like Growth Factor II Market

Due to the COVID-19 pandemic, the global Insulin Like Growth Factor II market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Dusigitumab accounting for % of the Insulin Like Growth Factor II global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Breast Cancer segment is altered to an % CAGR throughout this forecast period.
China Insulin Like Growth Factor II market size is valued at US$ million in 2021, while the US and Europe Insulin Like Growth Factor II are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Insulin Like Growth Factor II landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Insulin Like Growth Factor II include Boehringer Ingelheim GmbH, Genervon Biopharmaceuticals LLC and MedImmune LLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Insulin Like Growth Factor II Scope and Segment
Insulin Like Growth Factor II market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Insulin Like Growth Factor II market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Dusigitumab
M-630
GM-6
M-610.27
Xentuzumab
Others

Segment by Application

Breast Cancer
Hormone Sensitive Breast Cancer
Huntington Disease
Muscular Dystrophy
Others

BY COMPANY

Boehringer Ingelheim GmbH
Genervon Biopharmaceuticals LLC
MedImmune LLC

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Insulin Like Growth Factor II Product Introduction
1.2 Market by Type
1.2.1 Global Insulin Like Growth Factor II Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Dusigitumab
1.2.3 M-630
1.2.4 GM-6
1.2.5 M-610.27
1.2.6 Xentuzumab
1.2.7 Others
1.3 Market by Application
1.3.1 Global Insulin Like Growth Factor II Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Breast Cancer
1.3.3 Hormone Sensitive Breast Cancer
1.3.4 Huntington Disease
1.3.5 Muscular Dystrophy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Insulin Like Growth Factor II Sales Estimates and Forecasts 2017-2028
2.2 Global Insulin Like Growth Factor II Revenue Estimates and Forecasts 2017-2028
2.3 Global Insulin Like Growth Factor II Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Insulin Like Growth Factor II Sales by Region
2.4.1 Global Insulin Like Growth Factor II Sales by Region (2017-2022)
2.4.2 Global Sales Insulin Like Growth Factor II by Region (2023-2028)
2.5 Global Insulin Like Growth Factor II Revenue by Region
2.5.1 Global Insulin Like Growth Factor II Revenue by Region (2017-2022)
2.5.2 Global Insulin Like Growth Factor II Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Insulin Like Growth Factor II Sales by Manufacturers
3.1.1 Global Top Insulin Like Growth Factor II Manufacturers by Sales (2017-2022)
3.1.2 Global Insulin Like Growth Factor II Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Insulin Like Growth Factor II in 2021
3.2 Global Insulin Like Growth Factor II Revenue by Manufacturers
3.2.1 Global Insulin Like Growth Factor II Revenue by Manufacturers (2017-2022)
3.2.2 Global Insulin Like Growth Factor II Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Like Growth Factor II Revenue in 2021
3.3 Global Insulin Like Growth Factor II Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Insulin Like Growth Factor II Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Insulin Like Growth Factor II Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Insulin Like Growth Factor II Sales by Type
4.1.1 Global Insulin Like Growth Factor II Historical Sales by Type (2017-2022)
4.1.2 Global Insulin Like Growth Factor II Forecasted Sales by Type (2023-2028)
4.1.3 Global Insulin Like Growth Factor II Sales Market Share by Type (2017-2028)
4.2 Global Insulin Like Growth Factor II Revenue by Type
4.2.1 Global Insulin Like Growth Factor II Historical Revenue by Type (2017-2022)
4.2.2 Global Insulin Like Growth Factor II Forecasted Revenue by Type (2023-2028)
4.2.3 Global Insulin Like Growth Factor II Revenue Market Share by Type (2017-2028)
4.3 Global Insulin Like Growth Factor II Price by Type
4.3.1 Global Insulin Like Growth Factor II Price by Type (2017-2022)
4.3.2 Global Insulin Like Growth Factor II Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Insulin Like Growth Factor II Sales by Application
5.1.1 Global Insulin Like Growth Factor II Historical Sales by Application (2017-2022)
5.1.2 Global Insulin Like Growth Factor II Forecasted Sales by Application (2023-2028)
5.1.3 Global Insulin Like Growth Factor II Sales Market Share by Application (2017-2028)
5.2 Global Insulin Like Growth Factor II Revenue by Application
5.2.1 Global Insulin Like Growth Factor II Historical Revenue by Application (2017-2022)
5.2.2 Global Insulin Like Growth Factor II Forecasted Revenue by Application (2023-2028)
5.2.3 Global Insulin Like Growth Factor II Revenue Market Share by Application (2017-2028)
5.3 Global Insulin Like Growth Factor II Price by Application
5.3.1 Global Insulin Like Growth Factor II Price by Application (2017-2022)
5.3.2 Global Insulin Like Growth Factor II Price Forecast by Application (2023-2028)
6 North America
6.1 North America Insulin Like Growth Factor II Market Size by Type
6.1.1 North America Insulin Like Growth Factor II Sales by Type (2017-2028)
6.1.2 North America Insulin Like Growth Factor II Revenue by Type (2017-2028)
6.2 North America Insulin Like Growth Factor II Market Size by Application
6.2.1 North America Insulin Like Growth Factor II Sales by Application (2017-2028)
6.2.2 North America Insulin Like Growth Factor II Revenue by Application (2017-2028)
6.3 North America Insulin Like Growth Factor II Market Size by Country
6.3.1 North America Insulin Like Growth Factor II Sales by Country (2017-2028)
6.3.2 North America Insulin Like Growth Factor II Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Insulin Like Growth Factor II Market Size by Type
7.1.1 Europe Insulin Like Growth Factor II Sales by Type (2017-2028)
7.1.2 Europe Insulin Like Growth Factor II Revenue by Type (2017-2028)
7.2 Europe Insulin Like Growth Factor II Market Size by Application
7.2.1 Europe Insulin Like Growth Factor II Sales by Application (2017-2028)
7.2.2 Europe Insulin Like Growth Factor II Revenue by Application (2017-2028)
7.3 Europe Insulin Like Growth Factor II Market Size by Country
7.3.1 Europe Insulin Like Growth Factor II Sales by Country (2017-2028)
7.3.2 Europe Insulin Like Growth Factor II Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Insulin Like Growth Factor II Market Size by Type
8.1.1 Asia Pacific Insulin Like Growth Factor II Sales by Type (2017-2028)
8.1.2 Asia Pacific Insulin Like Growth Factor II Revenue by Type (2017-2028)
8.2 Asia Pacific Insulin Like Growth Factor II Market Size by Application
8.2.1 Asia Pacific Insulin Like Growth Factor II Sales by Application (2017-2028)
8.2.2 Asia Pacific Insulin Like Growth Factor II Revenue by Application (2017-2028)
8.3 Asia Pacific Insulin Like Growth Factor II Market Size by Region
8.3.1 Asia Pacific Insulin Like Growth Factor II Sales by Region (2017-2028)
8.3.2 Asia Pacific Insulin Like Growth Factor II Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Insulin Like Growth Factor II Market Size by Type
9.1.1 Latin America Insulin Like Growth Factor II Sales by Type (2017-2028)
9.1.2 Latin America Insulin Like Growth Factor II Revenue by Type (2017-2028)
9.2 Latin America Insulin Like Growth Factor II Market Size by Application
9.2.1 Latin America Insulin Like Growth Factor II Sales by Application (2017-2028)
9.2.2 Latin America Insulin Like Growth Factor II Revenue by Application (2017-2028)
9.3 Latin America Insulin Like Growth Factor II Market Size by Country
9.3.1 Latin America Insulin Like Growth Factor II Sales by Country (2017-2028)
9.3.2 Latin America Insulin Like Growth Factor II Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Insulin Like Growth Factor II Market Size by Type
10.1.1 Middle East and Africa Insulin Like Growth Factor II Sales by Type (2017-2028)
10.1.2 Middle East and Africa Insulin Like Growth Factor II Revenue by Type (2017-2028)
10.2 Middle East and Africa Insulin Like Growth Factor II Market Size by Application
10.2.1 Middle East and Africa Insulin Like Growth Factor II Sales by Application (2017-2028)
10.2.2 Middle East and Africa Insulin Like Growth Factor II Revenue by Application (2017-2028)
10.3 Middle East and Africa Insulin Like Growth Factor II Market Size by Country
10.3.1 Middle East and Africa Insulin Like Growth Factor II Sales by Country (2017-2028)
10.3.2 Middle East and Africa Insulin Like Growth Factor II Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Corporation Information
11.1.2 Boehringer Ingelheim GmbH Overview
11.1.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor II Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor II Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boehringer Ingelheim GmbH Recent Developments
11.2 Genervon Biopharmaceuticals LLC
11.2.1 Genervon Biopharmaceuticals LLC Corporation Information
11.2.2 Genervon Biopharmaceuticals LLC Overview
11.2.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor II Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor II Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Genervon Biopharmaceuticals LLC Recent Developments
11.3 MedImmune LLC
11.3.1 MedImmune LLC Corporation Information
11.3.2 MedImmune LLC Overview
11.3.3 MedImmune LLC Insulin Like Growth Factor II Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 MedImmune LLC Insulin Like Growth Factor II Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 MedImmune LLC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Insulin Like Growth Factor II Industry Chain Analysis
12.2 Insulin Like Growth Factor II Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Insulin Like Growth Factor II Production Mode & Process
12.4 Insulin Like Growth Factor II Sales and Marketing
12.4.1 Insulin Like Growth Factor II Sales Channels
12.4.2 Insulin Like Growth Factor II Distributors
12.5 Insulin Like Growth Factor II Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Insulin Like Growth Factor II Industry Trends
13.2 Insulin Like Growth Factor II Market Drivers
13.3 Insulin Like Growth Factor II Market Challenges
13.4 Insulin Like Growth Factor II Market Restraints
14 Key Findings in The Global Insulin Like Growth Factor II Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Insulin Like Growth Factor II Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Dusigitumab
    Table 3. Major Manufacturers of M-630
    Table 4. Major Manufacturers of GM-6
    Table 5. Major Manufacturers of M-610.27
    Table 6. Major Manufacturers of Xentuzumab
    Table 7. Major Manufacturers of Others
    Table 8. Global Insulin Like Growth Factor II Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Insulin Like Growth Factor II Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Insulin Like Growth Factor II Sales by Region (2017-2022) & (K Pcs)
    Table 11. Global Insulin Like Growth Factor II Sales Market Share by Region (2017-2022)
    Table 12. Global Insulin Like Growth Factor II Sales by Region (2023-2028) & (K Pcs)
    Table 13. Global Insulin Like Growth Factor II Sales Market Share by Region (2023-2028)
    Table 14. Global Insulin Like Growth Factor II Revenue by Region (2017-2022) & (US$ Million)
    Table 15. Global Insulin Like Growth Factor II Revenue Market Share by Region (2017-2022)
    Table 16. Global Insulin Like Growth Factor II Revenue by Region (2023-2028) & (US$ Million)
    Table 17. Global Insulin Like Growth Factor II Revenue Market Share by Region (2023-2028)
    Table 18. Global Insulin Like Growth Factor II Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 19. Global Insulin Like Growth Factor II Sales Share by Manufacturers (2017-2022)
    Table 20. Global Insulin Like Growth Factor II Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 21. Global Insulin Like Growth Factor II Revenue Share by Manufacturers (2017-2022)
    Table 22. Insulin Like Growth Factor II Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 23. Global Insulin Like Growth Factor II Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Insulin Like Growth Factor II by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Like Growth Factor II as of 2021)
    Table 25. Insulin Like Growth Factor II Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Insulin Like Growth Factor II Product Offered
    Table 27. Date of Manufacturers Enter into Insulin Like Growth Factor II Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Insulin Like Growth Factor II Sales by Type (2017-2022) & (K Pcs)
    Table 30. Global Insulin Like Growth Factor II Sales by Type (2023-2028) & (K Pcs)
    Table 31. Global Insulin Like Growth Factor II Sales Share by Type (2017-2022)
    Table 32. Global Insulin Like Growth Factor II Sales Share by Type (2023-2028)
    Table 33. Global Insulin Like Growth Factor II Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Global Insulin Like Growth Factor II Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Global Insulin Like Growth Factor II Revenue Share by Type (2017-2022)
    Table 36. Global Insulin Like Growth Factor II Revenue Share by Type (2023-2028)
    Table 37. Insulin Like Growth Factor II Price by Type (2017-2022) & (USD/Pcs)
    Table 38. Global Insulin Like Growth Factor II Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 39. Global Insulin Like Growth Factor II Sales by Application (2017-2022) & (K Pcs)
    Table 40. Global Insulin Like Growth Factor II Sales by Application (2023-2028) & (K Pcs)
    Table 41. Global Insulin Like Growth Factor II Sales Share by Application (2017-2022)
    Table 42. Global Insulin Like Growth Factor II Sales Share by Application (2023-2028)
    Table 43. Global Insulin Like Growth Factor II Revenue by Application (2017-2022) & (US$ Million)
    Table 44. Global Insulin Like Growth Factor II Revenue by Application (2023-2028) & (US$ Million)
    Table 45. Global Insulin Like Growth Factor II Revenue Share by Application (2017-2022)
    Table 46. Global Insulin Like Growth Factor II Revenue Share by Application (2023-2028)
    Table 47. Insulin Like Growth Factor II Price by Application (2017-2022) & (USD/Pcs)
    Table 48. Global Insulin Like Growth Factor II Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 49. North America Insulin Like Growth Factor II Sales by Type (2017-2022) & (K Pcs)
    Table 50. North America Insulin Like Growth Factor II Sales by Type (2023-2028) & (K Pcs)
    Table 51. North America Insulin Like Growth Factor II Revenue by Type (2017-2022) & (US$ Million)
    Table 52. North America Insulin Like Growth Factor II Revenue by Type (2023-2028) & (US$ Million)
    Table 53. North America Insulin Like Growth Factor II Sales by Application (2017-2022) & (K Pcs)
    Table 54. North America Insulin Like Growth Factor II Sales by Application (2023-2028) & (K Pcs)
    Table 55. North America Insulin Like Growth Factor II Revenue by Application (2017-2022) & (US$ Million)
    Table 56. North America Insulin Like Growth Factor II Revenue by Application (2023-2028) & (US$ Million)
    Table 57. North America Insulin Like Growth Factor II Sales by Country (2017-2022) & (K Pcs)
    Table 58. North America Insulin Like Growth Factor II Sales by Country (2023-2028) & (K Pcs)
    Table 59. North America Insulin Like Growth Factor II Revenue by Country (2017-2022) & (US$ Million)
    Table 60. North America Insulin Like Growth Factor II Revenue by Country (2023-2028) & (US$ Million)
    Table 61. Europe Insulin Like Growth Factor II Sales by Type (2017-2022) & (K Pcs)
    Table 62. Europe Insulin Like Growth Factor II Sales by Type (2023-2028) & (K Pcs)
    Table 63. Europe Insulin Like Growth Factor II Revenue by Type (2017-2022) & (US$ Million)
    Table 64. Europe Insulin Like Growth Factor II Revenue by Type (2023-2028) & (US$ Million)
    Table 65. Europe Insulin Like Growth Factor II Sales by Application (2017-2022) & (K Pcs)
    Table 66. Europe Insulin Like Growth Factor II Sales by Application (2023-2028) & (K Pcs)
    Table 67. Europe Insulin Like Growth Factor II Revenue by Application (2017-2022) & (US$ Million)
    Table 68. Europe Insulin Like Growth Factor II Revenue by Application (2023-2028) & (US$ Million)
    Table 69. Europe Insulin Like Growth Factor II Sales by Country (2017-2022) & (K Pcs)
    Table 70. Europe Insulin Like Growth Factor II Sales by Country (2023-2028) & (K Pcs)
    Table 71. Europe Insulin Like Growth Factor II Revenue by Country (2017-2022) & (US$ Million)
    Table 72. Europe Insulin Like Growth Factor II Revenue by Country (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Insulin Like Growth Factor II Sales by Type (2017-2022) & (K Pcs)
    Table 74. Asia Pacific Insulin Like Growth Factor II Sales by Type (2023-2028) & (K Pcs)
    Table 75. Asia Pacific Insulin Like Growth Factor II Revenue by Type (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Insulin Like Growth Factor II Revenue by Type (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Insulin Like Growth Factor II Sales by Application (2017-2022) & (K Pcs)
    Table 78. Asia Pacific Insulin Like Growth Factor II Sales by Application (2023-2028) & (K Pcs)
    Table 79. Asia Pacific Insulin Like Growth Factor II Revenue by Application (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Insulin Like Growth Factor II Revenue by Application (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Insulin Like Growth Factor II Sales by Region (2017-2022) & (K Pcs)
    Table 82. Asia Pacific Insulin Like Growth Factor II Sales by Region (2023-2028) & (K Pcs)
    Table 83. Asia Pacific Insulin Like Growth Factor II Revenue by Region (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Insulin Like Growth Factor II Revenue by Region (2023-2028) & (US$ Million)
    Table 85. Latin America Insulin Like Growth Factor II Sales by Type (2017-2022) & (K Pcs)
    Table 86. Latin America Insulin Like Growth Factor II Sales by Type (2023-2028) & (K Pcs)
    Table 87. Latin America Insulin Like Growth Factor II Revenue by Type (2017-2022) & (US$ Million)
    Table 88. Latin America Insulin Like Growth Factor II Revenue by Type (2023-2028) & (US$ Million)
    Table 89. Latin America Insulin Like Growth Factor II Sales by Application (2017-2022) & (K Pcs)
    Table 90. Latin America Insulin Like Growth Factor II Sales by Application (2023-2028) & (K Pcs)
    Table 91. Latin America Insulin Like Growth Factor II Revenue by Application (2017-2022) & (US$ Million)
    Table 92. Latin America Insulin Like Growth Factor II Revenue by Application (2023-2028) & (US$ Million)
    Table 93. Latin America Insulin Like Growth Factor II Sales by Country (2017-2022) & (K Pcs)
    Table 94. Latin America Insulin Like Growth Factor II Sales by Country (2023-2028) & (K Pcs)
    Table 95. Latin America Insulin Like Growth Factor II Revenue by Country (2017-2022) & (US$ Million)
    Table 96. Latin America Insulin Like Growth Factor II Revenue by Country (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Insulin Like Growth Factor II Sales by Type (2017-2022) & (K Pcs)
    Table 98. Middle East and Africa Insulin Like Growth Factor II Sales by Type (2023-2028) & (K Pcs)
    Table 99. Middle East and Africa Insulin Like Growth Factor II Revenue by Type (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Insulin Like Growth Factor II Revenue by Type (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Insulin Like Growth Factor II Sales by Application (2017-2022) & (K Pcs)
    Table 102. Middle East and Africa Insulin Like Growth Factor II Sales by Application (2023-2028) & (K Pcs)
    Table 103. Middle East and Africa Insulin Like Growth Factor II Revenue by Application (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Insulin Like Growth Factor II Revenue by Application (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Insulin Like Growth Factor II Sales by Country (2017-2022) & (K Pcs)
    Table 106. Middle East and Africa Insulin Like Growth Factor II Sales by Country (2023-2028) & (K Pcs)
    Table 107. Middle East and Africa Insulin Like Growth Factor II Revenue by Country (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Insulin Like Growth Factor II Revenue by Country (2023-2028) & (US$ Million)
    Table 109. Boehringer Ingelheim GmbH Corporation Information
    Table 110. Boehringer Ingelheim GmbH Description and Major Businesses
    Table 111. Boehringer Ingelheim GmbH Insulin Like Growth Factor II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 112. Boehringer Ingelheim GmbH Insulin Like Growth Factor II Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Boehringer Ingelheim GmbH Recent Developments
    Table 114. Genervon Biopharmaceuticals LLC Corporation Information
    Table 115. Genervon Biopharmaceuticals LLC Description and Major Businesses
    Table 116. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 117. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor II Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Genervon Biopharmaceuticals LLC Recent Developments
    Table 119. MedImmune LLC Corporation Information
    Table 120. MedImmune LLC Description and Major Businesses
    Table 121. MedImmune LLC Insulin Like Growth Factor II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 122. MedImmune LLC Insulin Like Growth Factor II Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. MedImmune LLC Recent Developments
    Table 124. Key Raw Materials Lists
    Table 125. Raw Materials Key Suppliers Lists
    Table 126. Insulin Like Growth Factor II Distributors List
    Table 127. Insulin Like Growth Factor II Customers List
    Table 128. Insulin Like Growth Factor II Market Trends
    Table 129. Insulin Like Growth Factor II Market Drivers
    Table 130. Insulin Like Growth Factor II Market Challenges
    Table 131. Insulin Like Growth Factor II Market Restraints
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Insulin Like Growth Factor II Product Picture
    Figure 3. Global Insulin Like Growth Factor II Market Share by Type in 2021 & 2028
    Figure 3. Dusigitumab Product Picture
    Figure 4. M-630 Product Picture
    Figure 5. GM-6 Product Picture
    Figure 6. M-610.27 Product Picture
    Figure 7. Xentuzumab Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Insulin Like Growth Factor II Market Share by Application in 2021 & 2028
    Figure 10. Breast Cancer
    Figure 11. Hormone Sensitive Breast Cancer
    Figure 12. Huntington Disease
    Figure 13. Muscular Dystrophy
    Figure 14. Others
    Figure 15. Insulin Like Growth Factor II Report Years Considered
    Figure 16. Global Insulin Like Growth Factor II Sales 2017-2028 (K Pcs)
    Figure 17. Global Insulin Like Growth Factor II Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Insulin Like Growth Factor II Revenue 2017-2028 (US$ Million)
    Figure 19. Global Insulin Like Growth Factor II Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 20. Global Insulin Like Growth Factor II Sales Market Share by Region (2017-2022)
    Figure 21. Global Insulin Like Growth Factor II Sales Market Share by Region (2023-2028)
    Figure 22. North America Insulin Like Growth Factor II Sales YoY (2017-2028) & (K Pcs)
    Figure 23. North America Insulin Like Growth Factor II Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Insulin Like Growth Factor II Sales YoY (2017-2028) & (K Pcs)
    Figure 25. Europe Insulin Like Growth Factor II Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Insulin Like Growth Factor II Sales YoY (2017-2028) & (K Pcs)
    Figure 27. Asia-Pacific Insulin Like Growth Factor II Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Latin America Insulin Like Growth Factor II Sales YoY (2017-2028) & (K Pcs)
    Figure 29. Latin America Insulin Like Growth Factor II Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. Middle East & Africa Insulin Like Growth Factor II Sales YoY (2017-2028) & (K Pcs)
    Figure 31. Middle East & Africa Insulin Like Growth Factor II Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. The Insulin Like Growth Factor II Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 33. The Top 5 and 10 Largest Manufacturers of Insulin Like Growth Factor II in the World: Market Share by Insulin Like Growth Factor II Revenue in 2021
    Figure 34. Global Insulin Like Growth Factor II Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 35. Global Insulin Like Growth Factor II Sales Market Share by Type (2017-2028)
    Figure 36. Global Insulin Like Growth Factor II Revenue Market Share by Type (2017-2028)
    Figure 37. Global Insulin Like Growth Factor II Sales Market Share by Application (2017-2028)
    Figure 38. Global Insulin Like Growth Factor II Revenue Market Share by Application (2017-2028)
    Figure 39. North America Insulin Like Growth Factor II Sales Market Share by Type (2017-2028)
    Figure 40. North America Insulin Like Growth Factor II Revenue Market Share by Type (2017-2028)
    Figure 41. North America Insulin Like Growth Factor II Sales Market Share by Application (2017-2028)
    Figure 42. North America Insulin Like Growth Factor II Revenue Market Share by Application (2017-2028)
    Figure 43. North America Insulin Like Growth Factor II Sales Share by Country (2017-2028)
    Figure 44. North America Insulin Like Growth Factor II Revenue Share by Country (2017-2028)
    Figure 45. U.S. Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 46. Canada Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 47. Europe Insulin Like Growth Factor II Sales Market Share by Type (2017-2028)
    Figure 48. Europe Insulin Like Growth Factor II Revenue Market Share by Type (2017-2028)
    Figure 49. Europe Insulin Like Growth Factor II Sales Market Share by Application (2017-2028)
    Figure 50. Europe Insulin Like Growth Factor II Revenue Market Share by Application (2017-2028)
    Figure 51. Europe Insulin Like Growth Factor II Sales Share by Country (2017-2028)
    Figure 52. Europe Insulin Like Growth Factor II Revenue Share by Country (2017-2028)
    Figure 53. Germany Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 54. France Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 55. U.K. Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 56. Italy Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 57. Russia Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 58. Asia Pacific Insulin Like Growth Factor II Sales Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Insulin Like Growth Factor II Revenue Market Share by Type (2017-2028)
    Figure 60. Asia Pacific Insulin Like Growth Factor II Sales Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Insulin Like Growth Factor II Revenue Market Share by Application (2017-2028)
    Figure 62. Asia Pacific Insulin Like Growth Factor II Sales Share by Region (2017-2028)
    Figure 63. Asia Pacific Insulin Like Growth Factor II Revenue Share by Region (2017-2028)
    Figure 64. China Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 65. Japan Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 66. South Korea Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 67. India Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 68. Australia Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 69. Taiwan Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 70. Indonesia Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 71. Thailand Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 72. Malaysia Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 73. Philippines Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 74. Latin America Insulin Like Growth Factor II Sales Market Share by Type (2017-2028)
    Figure 75. Latin America Insulin Like Growth Factor II Revenue Market Share by Type (2017-2028)
    Figure 76. Latin America Insulin Like Growth Factor II Sales Market Share by Application (2017-2028)
    Figure 77. Latin America Insulin Like Growth Factor II Revenue Market Share by Application (2017-2028)
    Figure 78. Latin America Insulin Like Growth Factor II Sales Share by Country (2017-2028)
    Figure 79. Latin America Insulin Like Growth Factor II Revenue Share by Country (2017-2028)
    Figure 80. Mexico Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 81. Brazil Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 82. Argentina Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 83. Middle East and Africa Insulin Like Growth Factor II Sales Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Insulin Like Growth Factor II Revenue Market Share by Type (2017-2028)
    Figure 85. Middle East and Africa Insulin Like Growth Factor II Sales Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Insulin Like Growth Factor II Revenue Market Share by Application (2017-2028)
    Figure 87. Middle East and Africa Insulin Like Growth Factor II Sales Share by Country (2017-2028)
    Figure 88. Middle East and Africa Insulin Like Growth Factor II Revenue Share by Country (2017-2028)
    Figure 89. Turkey Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 90. Saudi Arabia Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 91. U.A.E Insulin Like Growth Factor II Revenue (2017-2028) & (US$ Million)
    Figure 92. Insulin Like Growth Factor II Value Chain
    Figure 93. Insulin Like Growth Factor II Production Process
    Figure 94. Channels of Distribution
    Figure 95. Distributors Profiles
    Figure 96. Bottom-up and Top-down Approaches for This Report
    Figure 97. Data Triangulation
    Figure 98. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Marine Bio Products Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Marine Bio Products Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-34E5025
Fri Sep 23 00:00:00 UTC 2022

Add to Cart

Global Potassium Tert Butoxide Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Potassium Tert-Butoxide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-25B5115
Fri Sep 23 00:00:00 UTC 2022

Add to Cart

Global Medical Specialty Enzymes Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
Global Medical Specialty Enzymes Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-13Z12247
Fri Sep 23 00:00:00 UTC 2022

Add to Cart

China Aptamers Market Report Forecast 2021 2027
Global Aptamers Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-07
Fri Sep 23 00:00:00 UTC 2022

Add to Cart